Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.720 | 0.720 | 0.000 |
Stocks | 99.280 | 99.280 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.058 | 17.890 |
Price to Book | 5.599 | 2.922 |
Price to Sales | 4.647 | 2.145 |
Price to Cash Flow | 19.825 | 12.060 |
Dividend Yield | 1.452 | 2.073 |
5 Years Earnings Growth | 11.582 | 11.245 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.310 | 22.905 |
Healthcare | 19.840 | 13.988 |
Industrials | 14.690 | 11.773 |
Financial Services | 14.480 | 15.771 |
Communication Services | 6.580 | 7.511 |
Basic Materials | 6.120 | 4.309 |
Consumer Defensive | 4.630 | 8.030 |
Utilities | 2.340 | 2.682 |
Number of long holdings: 41
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 8.59 | - | - | |
Alphabet Inc Class A | - | 6.54 | - | - | |
Novo Nordisk B | DK0062498333 | 5.06 | 721.8 | -2.21% | |
ASML Holding | NL0010273215 | 4.85 | 631.50 | +2.43% | |
Taiwan Semiconductor Manufacturing Co Ltd ADR | - | 4.23 | - | - | |
Visa Inc Class A | - | 4.17 | - | - | |
Eli Lilly and Co | - | 4.17 | - | - | |
Intuit Inc | - | 3.42 | - | - | |
Thermo Fisher Scientific Inc | - | 3.24 | - | - | |
Synopsys Inc | - | 3.16 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest Engros Flexinv Aktier | 14.86B | 8.68 | 6.98 | 9.08 | ||
Danske Engros Global Equity Solutio | 9.68B | 17.83 | 8.72 | 9.98 | ||
Danske Engros Global Equity AkkW | 15.94B | 16.74 | 10.44 | 9.96 | ||
Danske Invest Engros Global Restric | 1.57B | 18.61 | 8.70 | 10.82 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review